The Food and Drug Administration on Thursday approved a core component of a brain implant made by Precision Neuroscience, a ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Rare diseases, often referred to as orphan diseases, affect small patient populations, yet collectively they impact more than ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

A novel drug for bloodstream infections, code-named VRP-034 and currently in the development stage pending final trials and ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...